Trials / Conditions / Epilepsy, Generalized

Epilepsy, Generalized

16 registered clinical trials studyying Epilepsy, Generalized — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Epileptic Psychoses and Their Link With Ictal Emotions and Consciousness NCT06960811	Central Hospital, Nancy, France	—
Recruiting	A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE NCT06769659	NeuroPro Therapeutics, Inc.	Phase 2
Recruiting	Baker Gordon Syndrome Natural History Study NCT06399952	University of Missouri-Columbia	—
Completed	Clinic to Community© Program for Adults With Epilepsy Admitted to Emergency Departments NCT04248920	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	N/A
Recruiting	ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures. NCT06579573	Ono Pharmaceutical Co., Ltd.	Phase 3
Completed	Helicobacter Pylori Eradication Therapy for Epileptic Children NCT05297695	Sohag University	Phase 2 / Phase 3
Completed	Evaluation of the 24/7 EEG™ SubQ System in Subjects With Uncontrolled Genetic Generalised Epilepsy Syndrome NCT05241678	Royal College of Surgeons, Ireland	—
Completed	Exercise for Memory Rehabilitation in Epilepsy NCT04959019	University of Alabama at Birmingham	N/A
Completed	Detecting Absence Seizures Using Eye Tracking NCT04439656	Rachel Kuperman	—
Completed	Severity: Quantifying the Severity of Generalized Tonic-clonic Seizures (GTCS) With Connected Devices NCT05477121	Centre Hospitalier Universitaire Vaudois	—
Completed	Clobazam in Patients With Lennox-Gastaut Syndrome NCT00518713	Lundbeck LLC	Phase 3
Completed	Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Inte NCT00319501	Pfizer	Phase 3
Completed	A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy NCT00266604	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 4
Completed	Clobazam in Subjects With Lennox-Gastaut Syndrome NCT00162981	Lundbeck LLC	Phase 2
Completed	A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed o NCT00231556	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3
Completed	Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients NCT00236886	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3